Widespread population immunity from prior SARS-CoV-2 infections and updated vaccines, combined with low-severity circulation of dominant variants such as XFG, underpins trader consensus that no new coronavirus pandemic will emerge in 2026. Official surveillance from the WHO and national agencies shows moderate global risk, with test positivity around 2-15% during recent seasonal upticks but no rise in hospitalizations or deaths comparable to earlier waves. The virus continues to evolve within established lineages without evidence of a novel strain or zoonotic spillover meeting pandemic criteria. A realistic shift could occur if a new variant demonstrates both substantial immune evasion and markedly higher virulence, or if an unrelated coronavirus emerges with efficient human-to-human transmission and severe outcomes before year-end monitoring concludes.